Surgery for bilateral outflow tract obstruction in elastin arteriopathy  by Stamm, Christof et al.
SVAS has been identified as a chromosomal microdele-
tion at 7q11.23, including the elastin gene.1 The result-
ing decrease in elastin expression during development
The underlying cause for congenital supravalvularaortic stenosis (SVAS) in patients with Williams
syndrome, familial SVAS, and probably also sporadic
Objective: A number of patients with Williams syndrome or other forms of
elastin arteriopathy have stenoses of pulmonary arteries in addition to
supravalvular aortic stenosis. We sought to investigate the effect of the
degree of pulmonary arterial stenosis on the prognosis after an operation for
supravalvular aortic stenosis to help define the optimal treatment strategy for
patients with severe forms of elastin arteriopathy.
Methods: Between 1960 and 1999, 33 patients underwent operations for
supravalvular aortic stenosis while having significant stenoses of the pul-
monary arteries. We retrospectively reviewed patient charts, obtained cur-
rent follow-up information, and determined risk factors for survival and
reoperation.
Results: Fifteen patients with moderate right-sided obstructions (confirmed
by pulmonary artery Z-scores and right ventricular/descending aortic pres-
sure ratio) underwent operations for supravalvular aortic stenosis only.
Eighteen patients had more severe right-sided obstructions and underwent
surgical relief of pulmonary arterial stenoses or right ventricular outflow
tract obstruction in addition to operations for supravalvular aortic stenosis.
Eight patients had undergone preoperative balloon dilations of stenotic pul-
monary arteries. There were 6 early deaths and 1 late death in our series.
Survival at 10 and 20 years was 76% (70% confidence interval, 68%-84%)
and freedom from reintervention was 59% (70% confidence interval, 46%-
71%) at 10 years and 49% (70% confidence interval, 35%-62%) at 20 years.
Multivariate analysis revealed that patients with a right ventricular/descend-
ing aortic pressure ratio of 1.0 or more were at higher risk for reintervention
but not for death.
Conclusions: Surgical treatment of pulmonary artery obstructions in elastin
arteriopathy is palliative but, in conjunction with balloon dilation of periph-
eral pulmonary arteries, offers good long-term survival to patients with the
severest form of elastin arteriopathy. (J Thorac Cardiovasc Surg
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is associated with an increased number of elastin lamel-
lae and excessive accumulation of collagen and smooth
muscle cells in the vascular wall, resulting in formation
of severely thickened and rigid arterial vessels.2-4 This
elastin arteriopathy is not a localized process but rather
a generalized disease of both the systemic and pul-
monary arterial systems.5-7 Although in many patients
with SVAS only the aortic obstruction is of clinical rel-
evance, obstructions of the pulmonary vasculature are
frequently observed.8-11 Peripheral pulmonary arterial
stenosis has long been acknowledged as part of
Williams syndrome, and central pulmonary artery
stenosis is often found.12 Patients with elastin arteri-
opathy may also have pulmonary artery stenoses with-
out having relevant SVAS.9,13 Localized supravalvular
pulmonary stenosis has also been described,14,15
although it is the least frequent type of pulmonary
artery stenosis in elastin arteriopathy. Depending on the
degree of stenosis, right ventricular pressure overload
and biventricular hypertrophy may develop. Several
reports indicate that in the natural course of the disease,
the severity of pulmonary artery stenoses, and thus
right ventricular pressure load, decrease throughout
childhood and adolescence.10,13,16-18 However, there are
a number of patients with severe pulmonary artery
stenoses who require surgical treatment for SVAS
while also having significant right ventricular pressure
overload, and these patients may have a higher opera-
tive risk.
We have previously reported our institutional experi-
ence with surgical treatment of SVAS with respect to
aortic valve function.11 In this study we sought to (1)
examine the nature of pulmonary artery stenosis in these
patients in greater detail, (2) determine the effect of dif-
ferent degrees of pulmonary artery stenosis on the prog-
nosis after surgical treatment of SVAS, and (3) help
define the optimal treatment strategy on the basis of the
results of surgical relief of pulmonary artery obstruc-
tions as part of a generalized elastin arteriopathy.
Methods
This study is confined to patients who underwent an oper-
ation for SVAS at Children’s Hospital Boston between 1960
and 1999 and had concomitant pulmonary artery stenoses
indicating generalized elastin arteriopathy. Patients operated
on before August 1998 were also included in a study that ana-
lyzed the results of different techniques for reconstruction of
the aortic root in SVAS.11 The patients’ charts were reviewed,
and questionnaires were sent to physicians and cardiologists.
All available reports of cardiac catheterization, echocardiog-
raphy, and lung perfusion scans were reviewed. Patients or
parents were contacted and sent a questionnaire when no
recent follow-up information was available. The protocol was
approved by the Children’s Hospital Institutional Review
Board. The follow-up period ranged from between 5 months
and 34 years (mean 9.2 years), and cross-sectional follow-up
was complete for all patients as of June 1999.
Hemodynamic and morphometric measurements. Data
were obtained during routine clinical follow-up and reviewed
retrospectively. Preoperative left ventricular and aortic pres-
sure measurements were performed by cardiac catheteriza-
tion in 31 patients; the left ventricular–aortic pressure gradi-
ent at follow-up was assessed by Doppler echocardiography
in 16 patients and cardiac catheterization in 13. Right ven-
tricular pressure was measured by means of preoperative car-
diac catheterization in 27 patients. Right heart catheterization
during follow-up was performed in 13 patients (3.2 ± 2.8,
median 1.5 years postoperatively). In 15 patients right ven-
tricular pressure at follow-up was derived from the peak
velocity of the tricuspid regurgitation jet, as measured by
Doppler echocardiography (performed 6.9 ± 3.1, median 5.4
years postoperatively). The right ventricle/descending tho-
racic aorta (RV/AoDT) pressure ratio was calculated to assess
right ventricular pressure load. The pulmonary artery diame-
ter was measured on anteroposterior angiograms in 24
patients preoperatively and in 13 patients at follow-up. Two-
dimensional echocardiography was used to measure the
diameter of the central pulmonary arteries at follow-up in 16
patients. Z-scores of pulmonary artery size for a given body
surface area were calculated by use of the diameter measured
midway between the origin and first branching point.
Calculations were based on the normal ranges reported by
Sievers and colleagues19 for measurements obtained from
angiograms and on an institutional database representative of
the local patient demographics for echocardiographic mea-
surements.20
Definitions. Central pulmonary artery stenosis was
defined as greater than 50% narrowing in diameter of the
main, left, or right pulmonary artery, as demonstrated by
angiography or echocardiography. Peripheral pulmonary
artery stenosis was defined as greater than 50% narrowing
distal to the pulmonary artery branching point at the hilum, as
demonstrated by angiography. Diffuse pulmonary artery
stenosis was defined as an angiographically diagnosed bilat-
eral hypoplasia involving the central and peripheral pul-
monary arteries. Discrete SVAS was defined as an hourglass-
shaped narrowing of the aorta at the level of the sinutubular
junction. A tubular narrowing involving the ascending aorta
or beyond was termed diffuse.
Statistical analysis. Estimated rates of survival and free-
dom from reoperation with 70% confidence intervals (CI)
were determined by the Kaplan-Meier product-limit method,
and survival curves were compared by the log-rank test. The
Cox proportional-hazards regression model was used to
establish the variables independently associated with each
outcome, with risk measured by the adjusted hazard ratio.21
Variables tested were as follows: surgical, interventional, or
both types of treatment of pulmonary artery stenosis; type of
SVAS (diffuse or discrete); and presence of diffuse pul-
monary artery stenosis. Age at the time of operation, year of
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operation, and RV/AoDT pressure ratio were investigated as
continuous variables. A forward stepwise selection procedure
was used to build the final multivariate models by means of
the variables stated above. Hemodynamic and morphometric
variables were evaluated by the Kolmogorov-Smirnov test to
ascertain whether the measurements follow a normal distrib-
ution. For variables having a skewed distribution, the Mann-
Whitney U test was used for between-group comparisons,
and the Wilcoxon signed-rank test was used for comparisons
of preoperative and follow-up data. Variables following a nor-
mal distribution (including Z-scores) were analyzed by
means of the appropriate parametric t test. The correlation
between patient age and the RV/AoDT pressure ratio was
tested by fitting the data to a nonlinear decay function of the
first order. Data were analyzed with the SPSS software pack-
age (version 9.0; SPSS Inc, Chicago, Ill).
Results
Thirty-three patients with SVAS and pulmonary artery
stenosis underwent operations at our institution. Thirteen
(39%) of the patients were male, and 20 (61%) were
female. Ages at operation ranged between 6 months and
16 years (mean 5.7 years; median 3.7 years). In 23
(70%) patients a diagnosis of Williams syndrome was
made by a medical geneticist and supported by fluores-
cence in situ hybridization analysis of a deletion on chro-
mosome 7q11.23. In 5 (15%) patients a familial history
of SVAS, generalized arteriopathy, or both, was known,
and the remaining 5 (15%) patients were classified as
sporadic cases. Associated cardiovascular anomalies
included patent ductus arteriosus (n = 1), atrial septal
defect (n = 1), small muscular ventricular septal defect
(n = 1), and stenosis of the left main coronary artery (n
= 1). Systemic arterial stenoses were demonstrated in 12
(36%) patients and involved renal arteries (n = 6) and
aortic arch branches (n = 9). Six patients had previously
undergone cardiovascular procedures other than balloon
dilations of pulmonary artery stenoses, including repair
of aortic coarctation (n = 4), division of a patent ductus
arteriosus (n = 1), and balloon dilation of a stenotic left
carotid and innominate artery.
Twenty (61%) patients were in New York Heart
Association functional class II to IV. One patient had
repeated syncopal episodes. Electrocardiographic evi-
dence, echocardiographic evidence, or both, of signifi-
cant biventricular hypertrophy was present in 28 (85%)
patients. Two patients underwent emergency operations
while receiving cardiopulmonary resuscitation after
cardiac arrest, one during diagnostic coronary angiog-
raphy and one during induction of anesthesia.
Left ventricular–aortic pressure gradients ranged
between 35 and 120 mm Hg, and right ventricular pres-
sures ranged between 30 and 200 mm Hg. The
RV/AoDT pressure ratios ranged between 0.3 and 2.8
(mean 0.9; median 0.75) and was greater than 1.0 in 9
patients. There was a nonlinear correlation between age
at the time of the investigation and the RV/AoDT pres-
sure ratio (Fig 1). Stenosis of the proximal right pul-
monary artery was demonstrated in 26 (79%) patients,
and stenosis of the left pulmonary artery was demon-
strated in 20 (61%) patients. Peripheral pulmonary
artery stenosis was present in all patients, usually
involving more than one lobar or segmental pulmonary
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Fig 1. Right ventricular/descending aortic (RV/AoDT) pres-
sure ratio as a function of age at investigation. Measurements
were obtained by means of preoperative right and left heart
catheterization in 25 patients. Nonlinear regression analysis
revealed a negative correlation between the RV/AoDT pres-
sure ratio and patient age (R = 0.65, R2 = 0.43, P = .0003).
Fig 2. Flow chart indicating the number of patients associ-
ated with a respective treatment or outcome. SVAS,
Supravalvular aortic stenosis; PAS, pulmonary artery
stenosis.
artery. Diffuse pulmonary artery stenosis was present in
12 (36%) patients. Pulmonary valve stenosis was found
in 9 patients, and a supravalvular narrowing of the main
pulmonary artery was found in 4. In 1 patient stenosis of
the right ventricular infundibulum was noted in addition
to a small pulmonary valve and stenoses of both the
right and left pulmonary arteries. Lung perfusion scans
were performed in 14 patients with more severe pul-
monary artery stenosis and demonstrated a marked per-
fusion mismatch in 7. As indicated by elevated right
atrial pressure (>10 mm Hg), 5 patients had evidence of
right ventricular failure. A systemic venous oxygen sat-
uration of less than 50%, which indicated insufficient
systemic perfusion, was found in 1 patient.
To illustrate the severity of the disease in patients
who were assigned to relief of right-sided obstructions,
Table I shows preoperative measurements grouped into
those undergoing or not undergoing treatment for pul-
monary artery stenosis. In 15 patients SVAS was
relieved, but pulmonary artery stenoses were not treat-
ed. These patients had less severe pulmonary artery
obstructions as demonstrated by lower RV/AoDT pres-
sure ratios and higher pulmonary artery Z-scores,
except 1 patient who was operated on for SVAS in 1960
with a RV/AoDT pressure of 1.6 but who did not under-
go relief of pulmonary artery stenosis. Eight patients
underwent 1 or more percutaneous balloon dilations of
pulmonary artery stenoses before surgical relief of
SVAS. In 7 of these procedures, the diameter of the
vessel was enlarged and the gradient across the steno-
sis decreased, as assessed immediately after balloon
dilation. Fifteen patients underwent surgical augmenta-
tion of stenotic pulmonary artery stenoses together
with operations for SVAS, and 2 of those patients also
had an intraoperative balloon angioplasty (Fig 2).
Operative technique. Techniques for augmentation
of the aortic sinutubular junction and ascending aorta
were described in detail in our previous report.11 Central
pulmonary arterial stenoses were augmented by inser-
tion of a pericardial patch after longitudinal incision of
the vessel in 9 patients. In 1 patient a proximal stenosis
of the right pulmonary artery was excised followed by
end-to-end anastomosis of the artery. Long-segment
stenoses of both the right and left pulmonary arteries
were treated by insertion of a pericardial patch through-
out both pulmonary arteries from the right to the left
hilum in 4 patients, in 2 of them in the form of a Y-
shaped patch to enlarge the main pulmonary artery also.
In 2 patients an inverted Y-shaped patch was inserted in
the main pulmonary artery and the right and left facing
sinuses to augment supravalvular pulmonary stenosis. In
3 patients with multilevel right ventricular outflow tract
obstruction, a transannular patch was inserted after inci-
sion of the infundibulum, pulmonary root, and main pul-
monary artery. In 1 patient with complex right ventricu-
lar outflow tract obstruction, a right ventricle–
pulmonary artery homograft conduit was implanted in
an orthotopic position supplemented by pericardial
patches enlarging the right ventricular infundibulum and
both branch pulmonary arteries. Peripheral pulmonary
artery stenoses were treated by intraoperative balloon
angioplasty in 2 patients.
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Table I. Preoperative measurements in patients with elastin arteriopathy, SVAS, and PAS
Total (n = 33) PAS not treated (n = 15) PAS treated (n = 18)
Age (y) at operation, median (range) 3.7 (0.5-16) 9.4 (1.4-16) 2.6 (0.5-6)*
LV–Ao pressure gradient (mm Hg) 85 ± 40 91 ± 42 75 ± 24
RV pressure (mm Hg) 81 ± 49 53 ± 26 104 ± 45*
RV/AoDT pressure ratio, median (range) 0.75 (0.3-2.8) 0.52 (0.3-1.6) 1.19 (0.7-2.8)*
Elevated RA pressure (>10 mm Hg), n 5 1 4
Diameter of RPA (Z-score) –2.1 ± 1.5† –1.1 ± 0.9 –3.4 ± 0.6*†
Diameter of LPA (Z-score) –1.3 ± 0.8† –0.9 ± 0.3† –1.6 ± 1*
Right PAS (n) 27 12 15
Left PAS (n) 21 11 10
Diffuse PAS (n) 12 7 5
Pulmonary valve stenosis (n) 9 2 7
Supravalvular pulmonary stenosis (n) 4 1 3
RV infundibular stenosis (n) 1 0 1
Lung perfusion mismatch (n) 7 NA 7
Data are shown for the entire cohort (Total) and separately for patients in whom treatment of both SVAS and pulmonary artery stenosis was indicated (PAS treated)
and patients who underwent operations for SVAS only (PAS not treated). Data are expressed as means ± SD where shown. SVAS, Supravalvular aortic stenosis; PAS,
pulmonary artery stenosis; LV-Ao, left ventricular–aortic; RV, right ventricular; RV/AoDT, right ventricular/descending thoracic aorta; RA, right atrial; RPA, right pul-
monary artery; LPA, left pulmonary artery; NA, Not applicable.
*P < .05 compared with PAS not treated (2-sample t test).
†P < .05 compared with the normal population mean of zero (1-sample t test).19,20
Reoperations or interventions. One patient was
reoperated on for restenosis at the distal end of the aor-
tic patch, and several procedures were performed for
recurrent or residual pulmonary artery stenosis. After
patch enlargement of the right pulmonary artery, early
restenosis developed in 1 patient at the site of the peri-
cardial patch, and the patch was replaced 1 year after
the initial operation. The patient who underwent
replacement of the right ventricular outflow tract by a
homograft had obstruction of the homograft with a gra-
dient of 50 mm Hg after 6.5 years. Attempted balloon
dilation of the stenotic homograft failed, and the steno-
sis was relieved by insertion of a generously sized pre-
clotted Dacron patch. In 6 patients, one or more bal-
loon dilations of pulmonary artery stenoses were
performed during the follow-up period, in 1 case
including placement of an intravascular stent. Overall
freedom from reoperation or intervention estimated by
the Kaplan-Meier method was 75% (70% CI, 66-84%)
at 5 years, 59% (70% CI, 46-71%) at 10 years, and
49% (70% CI, 35-62%) at 20 years (Fig 3, B).
Multivariable analysis revealed that patients with a pre-
operative RV/AoDT pressure ratio of 1.0 or greater
were at higher risk for reoperation or intervention (Fig
4, A). Six of the 9 patients who required reoperation
had an RV/AoDT pressure ratio of 1.0 or greater, and
20 of the 23 patients not requiring reoperation had a
pressure ratio of less than 1.0 (adjusted hazard ratio,
7.4; 70% CI, 3.6-14.9; P = .01). Cox regression also
revealed that patients with pulmonary artery stenoses
necessitating surgical or interventional treatment at the
time of operation for SVAS were more likely to under-
go reoperation or intervention during follow-up
(adjusted hazard ratio, 4.0; 70% CI, 1.5-10.8; P = .03).
Operation after 1987 also proved an independent risk
factor for reoperation or intervention (hazard ratio, 1.3;
70% CI, 1.1-1.6; P = .02), which may be influenced by
the fact that interventional treatment options for
patients with severe pulmonary artery stenosis were not
available before.
Mortality. There were 6 early deaths in our series.
Neither of the above-mentioned patients who under-
went emergency operations after cardiac arrest was
successfully weaned from bypass. Two other patients
had biventricular failure with low cardiac output and
were supported by extracorporeal membrane oxygena-
tion or a biventricular assist device, respectively.
Ventricular function did not recover, and both patients
died after circulatory support was discontinued. Two
patients earlier in the series died after cardiac arrest
when no mechanical support was available. One patient
with diffuse pulmonary artery stenosis, mild right pul-
monary artery stenosis, an aortic gradient of 100 mm
Hg, and an RV/AoDT pressure ratio of 0.64 died 5
years after single patch enlargement of the supravalvu-
lar aorta. Three years postoperatively, he had a residual
left ventricular gradient of 80 mm Hg and moderate
right ventricular hypertension (58 mm Hg; RV/AoDT
pressure ratio, 0.75), but he refused further surgical
treatment. An autopsy was performed, and the death
was attributed to left ventricular failure. Overall sur-
vival estimated by the Kaplan-Meier method was 81%
(70% CI, 78-92%) at 5 years and 76% (70% CI, 68-
84%) at 10 and 20 years (Fig 3, A). There was no cor-
relation between the RV/AoDT pressure ratio and sur-
vival. Because an RV/AoDT pressure ratio proved a
risk factor for reoperation or intervention, we also plot-
ted survival for these subsets of patients to demonstrate
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Fig 3. Kaplan-Meier estimated 20-year overall survival (A) and freedom from reoperation or intervention (B).
Error bars indicate the lower 70% CI. Number of patients at risk are shown in parentheses.
A B
that survival was not different for these patients (Fig 4,
B). Multivariate analysis identified none of the other
tested variables as risk factors of death.
Hemodynamics and symptoms at follow-up. The
left ventricular–aortic pressure gradients ranged
between 0 and 65 mm Hg. Right ventricular pressure
ranged between 24 and 100 mm Hg, and the RV/AoDT
pressure ratio ranged between 0.3 and 1.1. Both preop-
erative and postoperative RV/AoDT pressure ratios
were available for 20 patients (Fig 5). The RV/AoDT
pressure ratio decreased in 11 (100%) of 11 patients
who underwent treatment for pulmonary artery stenosis
and in 5 (59%) of 9 patients who underwent operations
for SVAS only. Five patients had an RV/AoDT pressure
ratio of greater than 0.7 at follow-up. Two patients were
in New York Heart Association functional class II, 2
patients had occasional chest pain on exertion, and a
further 2 patients had a syncopal episode, both of
unknown cause.
Discussion 
We have previously reported our institutional experi-
ence with surgical treatment for SVAS, and 41% of
these patients had concomitant stenoses of the right
ventricular outflow tract, pulmonary arteries, or both.11
The presence of a right-sided obstruction was not a risk
factor for survival or reoperation. Given that the sever-
ity of the pulmonary artery stenoses varies markedly,
we performed the present study to analyze the surgical
results in this subset of patients in greater detail. In 15
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Fig 4. Kaplan-Meier estimated 20-year freedom from reoperation or intervention (A) and survival (B) for patients
with elastin arteriopathy and suprasystemic right ventricular pressure (RV/AoDT pressure ratio > 1) and patients
with an RV/AoDT pressure ratio of less than 1. P values shown on the plots were calculated by the log-rank test.
Error bars indicate the lower 70% CI. Numbers of patients at risk are shown in parentheses; the group with an
RV/AoDT pressure ratio of less than 1 is shown in italics, and the group with an RV/AoDT pressure ratio of greater
than 1 is shown in boldface.
A B
Table II.  Postoperative measurements in patients with elastin arteriopathy, SVAS, and PAS
Total (n = 27) PAS not treated (n = 12) PAS treated (n = 15)
LV-Ao pressure gradient (mm Hg) 15 ± 9 16 ± 9 13 ± 8
RV pressure (mm Hg) 64 ± 21 63 ± 17 64 ± 15
RV/AoDT pressure ratio, median (range) 0.57 (0.2-1.1) 0.59 (0.2-1.1) 0.54 (0.4-0.8)
Elevated RAP (>10 mm Hg), n 2 0 2
Diameter of RPA (Z-score) –1.1 –1.0 ± 0.7 –1.1 ± 0.4
Diameter of LPA (Z-score) –0.4 –0.5 ± 0.2 –0.4 ± 0.5
Lung perfusion mismatch (n) 1 NA 1
Data are shown for the entire cohort (Total) and separately for patients in whom treatment of both SVAS and PAS was indicated (PAS treated) and patients who under-
went operations for SVAS only (PAS not treated). Data are expressed as means ± SD. SVAS, Supravalvular aortic stenosis; PAS, pulmonary artery stenosis; LV-Ao,
left ventricular–aortic; RV, right ventricular; RV/AoDT, right ventricular/descending thoracic aorta; RAP, right atrial pressure; RPA, right pulmonary artery; LPA, left
pulmonary artery; NA, Not applicable.
*P < .05 compared with PAS not treated (2-sample t test).
†P < .05 compared with the normal population (1-sample t test).19,20
patients with bilateral stenoses, treatment of right-sided
obstructions was not indicated at the time of operation
for SVAS, and none of these patients has required reop-
eration or intervention. The majority of these patients
had milder stenoses initially, and right ventricular pres-
sure load spontaneously decreased in 5 of 9 during fol-
low-up.
The opposite end of the spectrum is represented by
patients with severe, generalized, obstructive arteriopa-
thy, for whom the anatomic term macaroni arteriopathy
was coined. They usually have severe biventricular
pressure overload, are at exceedingly high risk of
myocardial ischemia, and are often deemed untreatable.
A large proportion of the patients who underwent treat-
ment of right-sided stenoses are very close to this end of
the spectrum. In addition to significant SVAS requiring
surgical reconstruction, the majority of these patients
had multiple pulmonary artery stenoses or complex
right ventricular outflow tract obstruction, resulting in
suprasystemic right ventricular pressure (Fig 6). They
were referred for surgical treatment at a significantly
younger age than patients with milder stenoses. Our
selective approach combining preoperative balloon dila-
tion of peripheral pulmonary artery stenoses and surgi-
cal relief of central stenoses at the time of operation for
SVAS resulted in a 20-year survival of 79% (Fig 4, B),
which is similar to the previously reported overall sur-
vival of patients with SVAS.11 We consider it important
to reduce right ventricular pressure overload before or at
the time of operation for SVAS because the ischemic
injury imposed on such severely hypertrophied hearts
during the repair can have deleterious effects in the
presence of excessively high afterload. The hypertro-
phied myocardium is more susceptible to ischemia,22,23
and in addition to our own experience, the literature
shows several reports of patients with elastin arteriopa-
thy who had right ventricular failure after the operation
for SVAS.11,17 Eight patients had previously undergone
balloon dilations of pulmonary arteries,24-27 so that in
combination with surgical enlargement of more proxi-
mal stenoses, right ventricular pressure load was
reduced before or at the time the heart was subjected to
global ischemia for repair of SVAS.
Some of these patients may still require intervention-
al treatment of residual, recurrent, or newly developed
pulmonary artery stenoses after the initial operation. It
is not clear whether balloon angioplasty of pulmonary
arteries in elastin arteriopathy is as effective as dilation
of other forms of pulmonary artery stenosis. The
decreased elasticity of the arteries may increase the risk
of rupture during balloon inflation, and smooth muscle
proliferation in elastin arteriopathy may result in earli-
er restenosis. We therefore aim at a generous patch
enlargement of pulmonary artery stenoses in elastin
arteriopathy whenever stenoses are proximal to the
lung hilum and as such accessible to the surgeon.
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Fig 5. RV/AoDT pressure ratio preoperatively and at follow-up. PAS not treated, Patients who underwent opera-
tions for SVAS only; PAS treated, patients who underwent operations for both SVAS and pulmonary artery steno-
sis. The P values displayed on the plots were determined by the paired Student t test. Follow-up measurements were
obtained 4.7 ± 2.9 years postoperatively (median 3.4 years). Horizontal bars indicate median.
Several reports have suggested that the severity of pul-
monary artery stenoses in Williams syndrome decreases
over time.10,13,16-18 However, it is notable that very few
of the patients included in these reports initially had
suprasystemic right ventricular pressure. A possible
explanation may be that these patients rarely reach the
age for a follow-up examination without undergoing
treatment or dying. We observed improvement of right
ventricular pressure overload without treatment in 5
patients. Because serial hemodynamic assessments are
frequently not available, in some reports the correlation
between patient age or body surface area and severity of
pulmonary artery stenoses has been used to support the
concept of improvement of pulmonary artery stenosis
over time.13,17 We also found a correlation between age
and severity of pulmonary artery stenosis (assessed by
RV/AoDT pressure ratio). However, as opposed to wait-
ing for spontaneous improvement of pulmonary artery
stenoses, we advocate an early relief of right-sided
obstructions to minimize the risk of an operation when
relief for SVAS is indicated.
Limitations of the study. As a retrospective study
based on a small number of patients with complete
functional follow-up but incomplete hemodynamic and
morphometric data, the statistical power of this analy-
sis is certainly limited. The patient selection was based
on clinical criteria (undergoing an operation for SVAS
while having significant pulmonary artery stenosis)
that are likely to influence the clinical course of the
patients. However, as we and others have pointed out
previously, the underlying disease is probably identical
in all patients with congenital SVAS. Furthermore, we
did not include patients with the same etiology who
underwent interventional treatment of right-sided
obstructions only.
Conclusion
In summary, we conclude that an individualized,
combined, cardiac surgical and interventional approach
to children with the severe forms of elastin arteriopa-
thy, biventricular pressure overload, and suprasystemic
right ventricular pressure results in favorable long-term
survival. However, generalized arteriopathy with
severe bilateral outflow tract obstruction and suprasys-
temic right ventricular pressures remains a surgical
challenge. Surgical treatment is palliative and requires
careful follow-up examinations and frequently addi-
tional pulmonary balloon angioplasty to ensure suc-
cessful long-term outcome.
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Fig 6. A, Pulmonary angiogram (right pulmonary artery) of a patient with diffuse pulmonary artery stenosis (age
3.7 years) at the time of diagnosis (RV/AoDT pressure ratio, 1.2; Z-scores: right pulmonary artery, –3.9; left pul-
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